{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T03:15:11Z","timestamp":1771038911498,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,8,17]],"date-time":"2017-08-17T00:00:00Z","timestamp":1502928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,8,17]],"date-time":"2017-08-17T00:00:00Z","timestamp":1502928000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>While anaesthetics are frequently used on cancer patients during surgical procedures, their consequence on cancer progression remains to be elucidated. In this study, we sought to investigate the influence of local anesthetics on lung cancer cell dissemination <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic>. A549 human non-small lung cancer cells were treated with various local anaesthetics including ropivacaine, lidocaine, levobupivacaine and bupivacaine. Cell barrier property was assessed using an electric cell-substrate impedance sensing (ECIS) system. The epithelial-to-mesenchymal transition (EMT) of treated cells was studied by immunofluorescence staining. <jats:italic>In vitro and in vivo<\/jats:italic> cancer cell dissemination were investigated.Gene expression microarray and quantitative real-time PCR (qrt-PCR) assays were used to identify the genes responsible for levobupivacaine-mediated cancer cell dissemination.The results illustrated that only levobupivacaine induced EMT in the treated cells and also caused the dissemination of cancer cells <jats:italic>in vitro<\/jats:italic>. In addition, after intravenous injection, levobupivacaine encouraged cancer cell dissemination <jats:italic>in vivo<\/jats:italic>. Gene expression microarray, qrt-PCR and immunoblotting revealed that after levobupivacaine treatment, the hypoxia-inducible factor (HIF)- 2\u03b1 gene was upregulated in cancer cells. Our findings suggest that levobupivacaine may induce A549 lung cancer cell dissemination both <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic>. More specifically, HIF-2\u03b1 signaling possibly contributes to levobupivacaine-mediated A549 lung cancer cell dissemination.<\/jats:p>","DOI":"10.1038\/s41598-017-08885-z","type":"journal-article","created":{"date-parts":[[2017,8,11]],"date-time":"2017-08-11T14:13:34Z","timestamp":1502460814000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Levobuipivacaine-Induced Dissemination of A549 Lung Cancer Cells"],"prefix":"10.1038","volume":"7","author":[{"given":"Shun-Ming","family":"Chan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo-Feng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Shung","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Ting","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Ting","family":"Chou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Fu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,17]]},"reference":[{"key":"8885_CR1","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1093\/annonc\/mdu138","volume":"25","author":"M Malvezzi","year":"2014","unstructured":"Malvezzi, M., Bertuccio, P., Levi, F., La Vecchia, C. & Negri, E. European cancer mortality predictions for the year 2014. Ann Oncol \n                           25, 1650\u20131656 (2014).","journal-title":"Ann Oncol"},{"key":"8885_CR2","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1200\/JCO.2010.30.5151","volume":"29","author":"H Iinuma","year":"2011","unstructured":"Iinuma, H. et al. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes\u2019 stage B and C colorectal cancer. J Clin Oncol \n                           29, 1547\u20131555 (2011).","journal-title":"J Clin Oncol"},{"key":"8885_CR3","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.1158\/1078-0432.CCR-05-0327","volume":"11","author":"SP Fraser","year":"2005","unstructured":"Fraser, S. P. et al. Voltage-gated sodium channel expression and potentiation of human breast cancer metastasis. Clin Cancer Res \n                           11, 5381\u20135389 (2005).","journal-title":"Clin Cancer Res"},{"key":"8885_CR4","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1093\/bja\/aeu221","volume":"113","author":"SP Fraser","year":"2014","unstructured":"Fraser, S. P., Foo, I. & Djamgoz, M. B. Local anaesthetic use in cancer surgery and disease recurrence: role of voltage-gated sodium channels? Br J Anaesth \n                           113, 899\u2013902 (2014).","journal-title":"Br J Anaesth"},{"key":"8885_CR5","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1097\/ALN.0b013e3182661977","volume":"117","author":"T Piegeler","year":"2012","unstructured":"Piegeler, T. et al. Antimetastatic potential of amide-linked local anesthetics: inhibition of lung adenocarcinoma cell migration and inflammatory Src signaling independent of sodium channel blockade. Anesthesiology \n                           117, 548\u2013559 (2012).","journal-title":"Anesthesiology"},{"key":"8885_CR6","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1097\/ALN.0b013e31824babfe","volume":"116","author":"E Lucchinetti","year":"2012","unstructured":"Lucchinetti, E. et al. Antiproliferative effects of local anesthetics on mesenchymal stem cells: potential implications for tumor spreading and wound healing. Anesthesiology \n                           116, 841\u2013856 (2012).","journal-title":"Anesthesiology"},{"key":"8885_CR7","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1093\/bja\/aeq164","volume":"105","author":"GL Snyder","year":"2010","unstructured":"Snyder, G. L. & Greenberg, S. Effect of anaesthetic technique and other perioperative factors on cancer recurrence. Br J Anaesth \n                           105, 106\u2013115 (2010).","journal-title":"Br J Anaesth"},{"key":"8885_CR8","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1097\/00000542-200610000-00008","volume":"105","author":"AK Exadaktylos","year":"2006","unstructured":"Exadaktylos, A. K., Buggy, D. J., Moriarty, D. C., Mascha, E. & Sessler, D. I. Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis? Anesthesiology \n                           105, 660\u2013664 (2006).","journal-title":"Anesthesiology"},{"key":"8885_CR9","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.jclinane.2015.02.007","volume":"27","author":"F Cassinello","year":"2015","unstructured":"Cassinello, F., Prieto, I., del Olmo, M., Rivas, S. & Strichartz, G. R. Cancer surgery: how may anaesthesia influence outcome? J Clin Anesth \n                           27, 262\u2013272 (2015).","journal-title":"J Clin Anesth"},{"key":"8885_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jclinane.2013.06.007","volume":"26","author":"JP Cata","year":"2014","unstructured":"Cata, J. P. et al. Effects of postoperative epidural analgesia on recurrence-free and overall survival in patients with nonsmall cell lung cancer. J Clin Anesth \n                           26, 3\u201317 (2014).","journal-title":"J Clin Anesth"},{"key":"8885_CR11","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jclinane.2012.12.007","volume":"25","author":"JP Cata","year":"2013","unstructured":"Cata, J. P. et al. Effects of surgery, general anaesthesia, and perioperative epidural analgesia on the immune function of patients with non-small cell lung cancer. J Clin Anesth \n                           25, 255\u2013262 (2013).","journal-title":"J Clin Anesth"},{"key":"8885_CR12","volume":"11","author":"OS Cakmakkaya","year":"2014","unstructured":"Cakmakkaya, O. S., Kolodzie, K., Apfel, C. C. & Pace, N. L. Anaesthetic techniques for risk of malignant tumour recurrence. Cochrane Database Syst Rev \n                           11, CD008877 (2014).","journal-title":"Cochrane Database Syst Rev"},{"key":"8885_CR13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000147748","volume":"154","author":"ED Hay","year":"1995","unstructured":"Hay, E. D. An overview of epithelio-mesenchymal transformation. Acta Anat \n                           154, 8\u201320 (1995).","journal-title":"Acta Anat"},{"key":"8885_CR14","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1093\/carcin\/bgn216","volume":"29","author":"S Cannito","year":"2008","unstructured":"Cannito, S. et al. Redox mechanisms switch on hypoxia-dependent epithelial-mesenchymal transition in cancer cells. Carcinogenesis \n                           29, 2267\u20132278 (2008).","journal-title":"Carcinogenesis"},{"key":"8885_CR15","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s10555-007-9055-1","volume":"26","author":"P Vaupel","year":"2007","unstructured":"Vaupel, P. & Mayer, A. Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev \n                           26, 225\u2013239 (2007).","journal-title":"Cancer Metastasis Rev"},{"key":"8885_CR16","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1213\/ANE.0b013e3181de0ab6","volume":"110","author":"A Gottschalk","year":"2010","unstructured":"Gottschalk, A., Sharma, S., Ford, J., Durieux, M. E. & Tiouririne, M. Review article: the role of the perioperative period in recurrence after cancer surgery. Anesth Analg \n                           110, 1636\u20131643 (2010).","journal-title":"Anesth Analg"},{"key":"8885_CR17","doi-asserted-by":"publisher","first-page":"4015","DOI":"10.1158\/0008-5472.CAN-10-4142","volume":"71","author":"MY Koh","year":"2011","unstructured":"Koh, M. Y., Lemos, R. Jr., Liu, X. & Powis, G. The hypoxia-associated factor switches cells from HIF-1alpha- to HIF-2alpha-dependent signaling promoting stem cell characteristics, aggressive tumor growth and invasion. Cancer Res \n                           71, 4015\u20134027 (2011).","journal-title":"Cancer Res"},{"key":"8885_CR18","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/ncb1691","volume":"10","author":"MH Yang","year":"2008","unstructured":"Yang, M. H. et al. Direct regulation of TWIST by HIF-1alpha promotes metastasis. Nat Cell Biol \n                           10, 295\u2013305 (2008).","journal-title":"Nat Cell Biol"},{"key":"8885_CR19","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s005400200011","volume":"16","author":"K Hirota","year":"2002","unstructured":"Hirota, K. Hypoxia-inducible factor 1, a master transcription factor of cellular hypoxic gene expression. J Anesth \n                           16, 150\u2013159 (2002).","journal-title":"J Anesth"},{"key":"8885_CR20","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nrc1187","volume":"3","author":"GL Semenza","year":"2003","unstructured":"Semenza, G. L. Targeting HIF-1 for cancer therapy. Nat Rev Cancer \n                           3, 721\u2013732 (2003).","journal-title":"Nat Rev Cancer"},{"key":"8885_CR21","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1158\/1541-7786.MCR-10-0568","volume":"9","author":"D Yao","year":"2011","unstructured":"Yao, D., Dai, C. & Peng, S. Mechanism of the mesenchymal-epithelial transition and its relationship with metastatic tumor formation. Mol Cancer Res \n                           9, 1608\u20131620 (2011).","journal-title":"Mol Cancer Res"},{"key":"8885_CR22","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1039\/C0AN00560F","volume":"136","author":"J Hong","year":"2011","unstructured":"Hong, J., Kandasamy, K., Marimuthu, M., Choi, C. S. & Kim, S. Electrical cell-substrate impedance sensing as a non-invasive tool for cancer cell study. Analyst \n                           136, 237\u2013245 (2011).","journal-title":"Analyst"},{"key":"8885_CR23","first-page":"5789","volume":"9","author":"S Ramasamy","year":"2014","unstructured":"Ramasamy, S., Bennet, D. & Kim, S. Drug and bioactive molecule screening based on a bioelectrical impedance cell culture platform. Int J Nanomedicine \n                           9, 5789\u20135809 (2014).","journal-title":"Int J Nanomedicine"},{"issue":"Suppl 1","key":"8885_CR24","doi-asserted-by":"publisher","first-page":"i17","DOI":"10.1093\/bja\/aes421","volume":"109","author":"A Heaney","year":"2012","unstructured":"Heaney, A. & Buggy, D. J. Can anaesthetic and analgesic techniques affect cancer recurrence or metastasis? Br J Anaesth \n                           109(Suppl 1), i17\u2013i28 (2012).","journal-title":"Br J Anaesth"},{"key":"8885_CR25","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/jcp.10145","volume":"192","author":"T Mammoto","year":"2002","unstructured":"Mammoto, T. et al. Infiltration anesthetic lidocaine inhibits cancer cell invasion by modulating ectodomain shedding of heparin-binding epidermal growth factor-like growth factor (HB-EGF). J Cell Physiol \n                           192, 351\u2013358 (2002).","journal-title":"J Cell Physiol"},{"key":"8885_CR26","first-page":"1","volume":"5","author":"L Mao","year":"2013","unstructured":"Mao, L., Lin, S. & Lin, J. The effects of anesthetics on tumor progression. Int J Physiol Pathophysiol Pharmacol \n                           5, 1\u201310 (2013).","journal-title":"Int J Physiol Pathophysiol Pharmacol"},{"key":"8885_CR27","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1213\/ANE.0b013e3182a94479","volume":"118","author":"YC Chang","year":"2014","unstructured":"Chang, Y. C. et al. Local anesthetics induce apoptosis in human breast tumor cells. Anesth Analg \n                           118, 116\u2013124 (2014).","journal-title":"Anesth Analg"},{"key":"8885_CR28","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.prp.2012.10.017","volume":"209","author":"Y Luan","year":"2013","unstructured":"Luan, Y. et al. Clinicopathological and prognostic significance of HIF-1alpha and HIF-2alpha expression in small cell lung cancer. Pathol Res Pract \n                           209, 184\u2013189 (2013).","journal-title":"Pathol Res Pract"},{"key":"8885_CR29","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/cgt.2008.71","volume":"16","author":"F Kamlah","year":"2009","unstructured":"Kamlah, F. et al. Intravenous injection of siRNA directed against hypoxia-inducible factors prolongs survival in a Lewis lung carcinoma cancer model. Cancer Gene Ther \n                           16, 195\u2013205 (2009).","journal-title":"Cancer Gene Ther"},{"key":"8885_CR30","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1054\/bjoc.2001.2018","volume":"85","author":"A Giatromanolaki","year":"2001","unstructured":"Giatromanolaki, A. et al. Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic\/molecular profile of tumours and survival. Br J Cancer \n                           85, 881\u2013890 (2001).","journal-title":"Br J Cancer"},{"key":"8885_CR31","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1158\/1078-0432.CCR-05-2049","volume":"12","author":"QT Le","year":"2006","unstructured":"Le, Q. T. et al. An evaluation of tumor oxygenation and gene expression in patients with early stage non-small cell lung cancers. Clin Cancer Res \n                           12, 1507\u20131514 (2006).","journal-title":"Clin Cancer Res"},{"key":"8885_CR32","doi-asserted-by":"publisher","first-page":"14182","DOI":"10.1073\/pnas.1001296107","volume":"107","author":"J Mazumdar","year":"2010","unstructured":"Mazumdar, J. et al. HIF-2alpha deletion promotes Kras-driven lung tumor development. Proc Natl Acad Sci USA \n                           107, 14182\u201314187 (2010).","journal-title":"Proc Natl Acad Sci USA"},{"key":"8885_CR33","doi-asserted-by":"publisher","first-page":"21306","DOI":"10.1073\/pnas.0906432106","volume":"106","author":"A Franovic","year":"2009","unstructured":"Franovic, A., Holterman, C. E., Payette, J. & Lee, S. Human cancers converge at the HIF-2alpha oncogenic axis. Proc Natl Acad Sci USA \n                           106, 21306\u201321311 (2009).","journal-title":"Proc Natl Acad Sci USA"},{"key":"8885_CR34","doi-asserted-by":"publisher","first-page":"14391","DOI":"10.1073\/pnas.0907357106","volume":"106","author":"JA Bertout","year":"2009","unstructured":"Bertout, J. A. et al. HIF2alpha inhibition promotes p53 pathway activity, tumor cell death, and radiation responses. Proc Natl Acad Sci USA \n                           106, 14391\u201314396 (2009).","journal-title":"Proc Natl Acad Sci USA"},{"key":"8885_CR35","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1164\/rccm.201009-1393PP","volume":"183","author":"LA Shimoda","year":"2011","unstructured":"Shimoda, L. A. & Semenza, G. L. HIF and the lung: role of hypoxia-inducible factors in pulmonary development and disease. Am J Respir Crit Care Med \n                           183, 152\u2013156 (2011).","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl 1","key":"8885_CR36","doi-asserted-by":"publisher","first-page":"i32","DOI":"10.1093\/bja\/aeu201","volume":"113","author":"P Lirk","year":"2014","unstructured":"Lirk, P., Hollmann, M. W., Fleischer, M., Weber, N. C. & Fiegl, H. Lidocaine and ropivacaine, but not bupivacaine, demethylate deoxyribonucleic acid in breast cancer cells in vitro. Br J Anaesth \n                           113(Suppl 1), i32\u201338 (2014).","journal-title":"Br J Anaesth"},{"key":"8885_CR37","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1097\/ALN.0b013e31829e47fd","volume":"119","author":"LL Benzonana","year":"2013","unstructured":"Benzonana, L. L. et al. Isoflurane, a commonly used volatile anesthetic, enhances renal cancer growth and malignant potential via the hypoxia-inducible factor cellular signaling pathway in vitro. Anesthesiology \n                           119, 593\u2013605 (2013).","journal-title":"Anesthesiology"},{"key":"8885_CR38","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s00540-011-1107-6","volume":"25","author":"AE Lauprecht","year":"2011","unstructured":"Lauprecht, A. E., Wenger, F. A., El Fadil, O., Walz, M. K. & Groeben, H. Levobupivacaine plasma concentrations following major liver resection. J Anesth \n                           25, 369\u2013375 (2011).","journal-title":"J Anesth"},{"key":"8885_CR39","first-page":"1163","volume":"81","author":"BM Emanuelsson","year":"1995","unstructured":"Emanuelsson, B. M., Zaric, D., Nydahl, P. A. & Axelsson, K. H. Pharmacokinetics of ropivacaine and bupivacaine during 21 hours of continuous epidural infusion in healthy male volunteers. Anesth Analg \n                           81, 1163\u20131168 (1995).","journal-title":"Anesth Analg"},{"key":"8885_CR40","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/BF03005464","volume":"37","author":"M Takasaki","year":"1990","unstructured":"Takasaki, M. & Kajitani, H. Plasma lidocaine concentrations during continuous epidural infusion of lidocaine with and without epinephrine. Can J Anaesth \n                           37, 166\u2013169 (1990).","journal-title":"Can J Anaesth"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-08885-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-08885-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-08885-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T08:52:51Z","timestamp":1671785571000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-08885-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,17]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["8885"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-08885-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,17]]},"assertion":[{"value":"18 April 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"8646"}}